13 results on '"Adegbola, Richard A"'
Search Results
2. Pneumococcal vaccination in developing countries.
- Author
-
Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, Dagan R, Goldblatt D, Grange A, Greenwood B, Hennessy T, Klugman KP, Madhi SA, Mulholland K, Nohynek H, Santosham M, Saha SK, Scott JA, Sow S, Whitney CG, and Cutts F
- Subjects
- Africa epidemiology, Child, Preschool, HIV Infections complications, Humans, Immunization Programs organization & administration, Immunization Programs trends, Infant, Pneumococcal Vaccines immunology, Pneumococcal Vaccines therapeutic use, Pneumonia, Pneumococcal epidemiology, Pneumonia, Pneumococcal mortality, Serotyping, Developing Countries, Pneumococcal Vaccines classification, Pneumonia, Pneumococcal prevention & control, Streptococcus pneumoniae pathogenicity
- Published
- 2006
- Full Text
- View/download PDF
3. The role of Chlamydia pneumoniae in acute respiratory tract infections in young children in The Gambia, West Africa.
- Author
-
Weber MW, Gopalakrishna G, Awomoyi A, Cunningham A, Adegbola RA, Falade AG, Ogunlesi OO, Whittle HC, and Mulholland EK
- Subjects
- Acute Disease, Case-Control Studies, Child, Preschool, Chlamydophila pneumoniae genetics, Female, Gambia, Genes, Bacterial, Humans, Infant, Male, Malnutrition, Pneumonia, Bacterial microbiology, Polymerase Chain Reaction methods, Respiratory Syncytial Virus Infections complications, Respiratory Syncytial Virus, Human isolation & purification, Chlamydophila Infections microbiology, Chlamydophila pneumoniae isolation & purification, Developing Countries, Respiratory Tract Infections microbiology
- Abstract
Background: Little is known about the role of Chlamydia pneumoniae in the aetiology of acute respiratory tract infections (ARI) in children in developing countries., Aims: To obtain better information, we studied the presence of C. pneumoniae and its association with clinical signs and symptoms of ARI in children under 5 years of age in The Gambia., Methods: C. pneumoniae was sought by polymerase chain reaction in nasopharyngeal secretions and/or lung puncture aspirates from 324 infants under 3 months of age and 325 children between 3 months and 5 years of age with malnutrition, with or without pneumonia, and in control children. Clinical signs and symptoms for ARI and the spectrum of other viral and bacterial organisms were compared between those positive for C. pneumoniae and those negative., Results: Of 324 young infants, ten (3.1%) showed the presence of C. pneumoniae whereas in the older children 50 of 325 (15%) were positive for C. pneumoniae. There was no significant association between clinical signs and symptoms of ARI and C. pneumoniae positivity in the young infants. Among older infants and children, there was a trend to more frequent lobar alveolar changes in those positive for C. pneumoniae. No bacterial pathogens were found to be significantly associated with C. pneumoniae infection. However, there was an association with measles in the malnutrition group and with RSV in the young infants group., Conclusions: In this study, C. pneumoniae was not associated with any particular clinical syndrome. We found no evidence that the organism plays a major role in ARI in young children in developing countries such as The Gambia.
- Published
- 2006
- Full Text
- View/download PDF
4. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
- Author
-
Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, Mulholland K, McAdam K, Greenwood B, and Milligan PJ
- Subjects
- Child, Preschool, Gambia epidemiology, Haemophilus Infections epidemiology, Humans, Incidence, Infant, Meningitis, Haemophilus epidemiology, Meningitis, Haemophilus prevention & control, Prevalence, Vaccines, Conjugate, Developing Countries, Haemophilus Infections prevention & control, Haemophilus Vaccines administration & dosage, Haemophilus influenzae type b, Immunization Programs, Tetanus Toxoid administration & dosage
- Abstract
Background: Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation on incidence of Hib disease., Methods: Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar., Findings: Between May, 1997, and April, 2002, a total of 5984 children were examined for possible Hib infections. 49 children had Hib disease, 36 of whom had meningitis. The annual incidence rates of Hib meningitis before any use of the vaccine (1990-93) dropped from over 200 per 100,000 children aged younger than 1 year to none per 100,000 in 2002, and from 60 to no cases per 100,000 in children younger than 5 years. The prevalence of Hib carriage decreased from 12% to 0.25% (p<0.0001). Two doses of vaccine were needed for direct protection from Hib disease (vaccine efficacy 94%, 95% CI 62-99). Since most children received a protective dose after the age of greatest disease risk, indirect effects were important in reducing disease incidence., Interpretation: The Gambian Hib immunisation programme reduced the occurrence of Hib disease despite irregular vaccine supply. The effect of the programme in The Gambia has important implications for the introduction of the vaccine into routine immunisation programmes of other developing countries.
- Published
- 2005
- Full Text
- View/download PDF
5. Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008-2015
- Author
-
Odutola, Aderonke, Bottomley, Christian, Zaman, Syed A., Lindsay, Jodi, Shah, Muhammed, Hossain, Ilias, Ndiaye, Malick, Osuorah, Chidebere D.I., Olatunji, Yekini, Badji, Henry, Ikumapayi, Usman N.A., Manjang, Ahmad, Salaudeen, Rasheed, Ceesay, Lamin, Jasseh, Momodou, Adegbola, Richard A., Corrah, Tumani, Hill, Philip C., Greenwood, Brian M., and Mackenzie, Grant A.
- Subjects
Staphylococcus aureus infections ,Bacteremia ,Pediatric diseases ,Staphylococcus aureus ,Blood tests ,Meningitis ,Pneumonia ,Medical research ,Epidemiology ,Developing countries ,Death ,Rural areas ,Intelligence gathering ,Newborn infants ,Infection ,Children ,Health - Abstract
In 2016, invasive bacterial diseases accounted for one quarter of the 5.6 million childhood deaths worldwide (1). Most invasive bacterial diseases occur in sub-Saharan Africa and other low- and middle-income [...]
- Published
- 2019
- Full Text
- View/download PDF
6. Childhood Pneumonia as a Global Health Priority and the Strategic Interest of The Bill & Melinda Gates Foundation
- Author
-
Adegbola, Richard A.
- Published
- 2012
- Full Text
- View/download PDF
7. Vaccination with a Haemophilus influenzae Type b Conjugate Vaccine Reduces Oropharyngeal Carriage of H. influenzae Type b among Gambian Children
- Author
-
Adegbola, Richard A., Mulholland, E. Kim, Secka, Ousman, Jaffar, Shabbar, and Greenwood, Brian M.
- Published
- 1998
8. Carriage of Group B Streptococci in Pregnant Gambian Mothers and Their Infants
- Author
-
Suara, Rahaman O., Adegbola, Richard A., Baker, Carol J., Secka, Ousman, Mulholland, Edward K., and Greenwood, Brian M.
- Published
- 1994
9. Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine.
- Author
-
Martellet, Lionel, Sow, Samba O., Diallo, Aldiouma, Hodgson, Abraham, Kampmann, Beate, Hirve, Siddhivinayak, Tapia, Milagritos, Haidara, Fadima Cheick, Ndiaye, Assane, Diarra, Bou, Ansah, Patrick Odum, Akinsola, Adebayo, Idoko, Olubukola T., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Viviani, Simonetta, Enwere, Godwin C., Marchetti, Elisa, and Chaumont, Julie
- Subjects
MENINGOCOCCAL vaccines ,CLINICAL trials & ethics ,INFORMED consent (Medical law) ,PREVENTIVE medicine ,HUMAN research subjects - Abstract
Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005 and 2013. During this period, the Meningitis Vaccine Project (MVP) accumulated substantial experience in the ethical conduct of research to the highest standards. Methods. Because of the public–private nature of the sponsorship of these trials and the extensive international collaboration with partners from a diverse setting of countries, the ethical review process was complex and required strategic, timely, and attentive communication to ensure the smooth review and approval for the clinical studies. Investigators and their site teams fostered strong community relationships prior to, during, and after the studies to ensure the involvement and the ownership of the research by the participating populations. As the clinical work proceeded, investigators and sponsors responded to specific questions of informed consent, pregnancy testing, healthcare, disease prevention, and posttrial access. Results. Key factors that led to success included (1) constant dialogue between partners to explore and answer all ethical questions; (2) alertness and preparedness for emerging ethical questions during the research and in the context of evolving international ethics standards; and (3) care to assure that approaches were acceptable in the diverse community contexts. Conclusions. Many of the ethical issues encountered during the PsA-TT clinical development are familiar to groups conducting field trials in different cultural settings. The successful approaches used by the MVP clinical team offer useful examples of how these problems were resolved. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. The Effectiveness of Conjugate Haemophilus influenzae Type B Vaccine in The Gambia 14 Years After Introduction.
- Author
-
Howie, Stephen R. C., Oluwalana, Claire, Secka, Ousman, Scott, Susana, Ideh, Readon C., Ebruke, Bernard E., Balloch, Anne, Sambou, Sana, Erskine, James, Lowe, Yamundow, Corrah, Tumani, and Adegbola, Richard A.
- Subjects
DRUG efficacy ,HAEMOPHILUS influenzae ,PREVENTIVE medicine ,DEVELOPING countries ,DRUG dosage ,MICROBIOLOGY ,VACCINATION - Abstract
Fourteen years after the first introduction of conjugate Haemophilus influenzae type b vaccine in The Gambia, effective disease control was maintained, with associated low carriage and high seroprotection. Continued surveillance must determine if protection wanes and a booster dose is needed.Background. The Gambia was the first country in Africa to introduce conjugate Haemophilus influenzae type b (Hib) vaccine, which, as in other developing countries but unlike industrialized countries, is delivered as a 3-dose primary series with no booster. This study assessed its effectiveness 14 years after introduction.Methods. Using methods standardized during >20 years in the study site, clinical and microbiological surveillance for invasive Hib disease (primarily meningitis) in the Western Region of The Gambia from 2007 to 2010 was complemented with studies of Hib carriage in children aged 1 to <2 years, Hib antibody levels in children aged <5 years, and Hib vaccine coverage and timing in children aged 1 to <2 years.Results. The incidence of Hib meningitis remained low (averaging 1.3 per 100 000 children aged <5 years annually), as did the Hib oropharyngeal carriage rate (0.9%). Hib antibody levels were protective in >99% of those surveyed, albeit with lower titers in older children; and coverage of conjugate Hib vaccination was high (91% having 3 doses at 1–2 years of age) using a schedule that was delivered at median ages of 2.6 months, 4.3 months, and 6 months for the first, second, and third doses, respectively.Conclusions. Conjugate Hib vaccine was delivered on time in a 3-dose primary series without booster to a high proportion of eligible children and this was associated with effective disease control up to 14 years after introduction. It is important that surveillance continues in this first African country to introduce the vaccine to determine if effective control persists or if a booster dose becomes necessary as has been the case in industrialized countries. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
11. Population Biology of Streptococcus pneumoniae in West Africa: Multilocus Sequence Typing of Serotypes That Exhibit Different Predisposition to Invasive Disease and Carriage.
- Author
-
Donkor, Eric S., Adegbola, Richard A., Wren, Brendan W., and Antonio, Martin
- Subjects
- *
POPULATION biology , *STREPTOCOCCUS pneumoniae ,DEVELOPING countries - Abstract
Background: Little is known about the population biology of Streptococcus pneumoniae in developing countries, although the majority of pneumococcal infections occur in this setting. The aim of the study was to apply MLST to investigate the population biology of S. pneumoniae in West Africa. Methods: Seventy three invasive and carriage S. pneumoniae isolates from three West African countries including The Gambia, Nigeria and Ghana were investigated. The isolates covered seven serotypes (1, 3, 5, 6A, 11, 14, 23F) and were subjected to multilocus sequence typing and antibiotic susceptibility testing. Results: Overall, 50 different sequence types (STs) were identified, of which 38% (29) were novel. The most common ST was a novel clone-ST 4012 (6.5%), and some clones including STs 913, 925, 1737, 2160 and 3310 appeared to be specific to the study region. Two STs including ST 63 and ST 4012 were associated with multiple serotypes indicating a history of serotype switching. ST 63 was associated with serotypes 3 and 23F, while ST 4012 was associated with serotypes 6A and 23. eBURST analyses using the stringent 6/7 identical loci definition grouped the 50 STs into 5 clonal complexes and 65 singletons, expressing a high level of genetic diversity among the isolates. Compared to the other serotypes, serotypes 1 and 5 isolates appeared to be more clonal. Internationally recognized antibiotic resistant clones of S. pneumoniae were generally absent in the population investigated and the only multidrug resistant isolate identified (1/66) belong to the Pneumocococcal Epidemiology Network clone ST 63. Conclusions: The pneumococcal population in West Africa is quite divergent, and serotypes that are common in invasive disease (such as serotypes 1 and 5) are more likely to be clonal than serotypes that are common in carriage. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
12. Clinical predictors of bacterial meningitis in infants and young children in The Gambia.
- Author
-
Weber, Martin W., Herman, Joanna, Jaffar, Shabbar, Usen, Stanley, Oparaugo, Anslem, Omosigho, Charles, Adegbola, Richard A., Greenwood, Brian M., and Mulholland, E. Kim
- Subjects
MENINGITIS in children ,JUVENILE diseases - Abstract
Background: Bacterial meningitis is an important cause of childhood morbidity and mortality world-wide. In the developing world, where the burden of acute meningitis and its long-term sequelae are especially high, staff with limited training at primary health care facilities must be able to recognize the symptoms and signs of meningitis, so that suspected cases can be referred urgently to hospitals.Methods: Children who presented with possible invasive bacterial infection to health facilities in The Gambia, West Africa, between 1993 and 1995 were investigated in a standardized manner and clinical findings were documented. Bacterial meningitis was defined as the growth of bacteria from the cerebrospinal fluid. Clinical findings were compared between cases of meningitis and other children.Results: Of 2097 children between 2 months and 3 years of age investigated, 51 had a confirmed diagnosis of bacterial meningitis. In multivariate analysis using a model adjusting for age but not including respiratory signs, the variables associated independently with meningitis were appearance of being very sick (odds ratio for meningitis vs. no meningitis or no lumbar puncture performed (OR) 4.1, 95% CI 1.5-11.1), being lethargic or unconscious (OR 5.2, 95% CI 2.1-13), a stiff neck (OR 29.3, 95% CI 12.2-70.3), a bulging fontanel (OR 3.2, 95% CI 1.2-8.5) and reduced feeding as a prompted complaint (OR 2.9, 95% CI 1.3-6.7). A combination model of a history of convulsions, or being lethargic or unconscious, or having a stiff neck, as used in the WHO-Integrated Management of Childhood Illness (IMCI) guidelines, had a sensitivity of 98% and a specificity of 72% to predict meningitis.Conclusions: A combination of a limited number of signs is sufficient to predict meningitis with high sensitivity, without a large number of children who do not have meningitis being unnecessarily referred. [ABSTRACT FROM AUTHOR]- Published
- 2002
- Full Text
- View/download PDF
13. The Global Enteric Multicenter Study (GEMS) of Diarrheal Disease in Infants and Young Children in Developing Countries: Epidemiologic and Clinical Methods of the Case/Control Study.
- Author
-
Kotloff, Karen L., Blackwelder, William C., Nasrin, Dilruba, Nataro, James P., Farag, Tamer H., van Eijk, Annemieke, Adegbola, Richard A., Alonso, Pedro L., Breiman, Robert F., Golam Faruque, Abu Syed, Saha, Debasish, Sow, Samba O., Sur, Dipika, Zaidi, Anita K. M., Biswas, Kousick, Panchalingam, Sandra, Clemens, John D., Cohen, Dani, Glass, Roger I., and Mintz, Eric D.
- Subjects
INTESTINAL infections ,DIARRHEA in children ,EPIDEMIOLOGY ,CASE-control method ,INFANT diseases ,DEVELOPING countries - Abstract
Background. Diarrhea is a leading cause of illness and death among children aged <5 years in developing countries. This paper describes the clinical and epidemiological methods used to conduct the Global Enteric Multicenter Study (GEMS), a 3-year, prospective, age-stratified, case/control study to estimate the population-based burden, microbiologic etiology, and adverse clinical consequences of acute moderate-to-severe diarrhea (MSD) among a censused population of children aged 0–59 months seeking care at health centers in sub-Saharan Africa and South Asia.Methods. GEMS was conducted at 7 field sites, each serving a population whose demography and healthcare utilization practices for childhood diarrhea were documented. We aimed to enroll 220 MSD cases per year from selected health centers serving each site in each of 3 age strata (0–11, 12–23, and 24–59 months), along with 1–3 matched community controls. Cases and controls supplied clinical, epidemiologic, and anthropometric data at enrollment and again approximately 60 days later, and provided enrollment stool specimens for identification and characterization of potential diarrheal pathogens. Verbal autopsy was performed if a child died. Analytic strategies will calculate the fraction of MSD attributable to each pathogen and the incidence, financial costs, nutritional consequences, and case fatality overall and by pathogen.Conclusions. When completed, GEMS will provide estimates of the incidence, etiology, and outcomes of MSD among infants and young children in sub-Saharan Africa and South Asia. This information can guide development and implementation of public health interventions to diminish morbidity and mortality from diarrheal diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.